English Data Summary
Back to reportsCompany Profile
Dizal (Jiangsu) Pharmaceutical Co., Ltd. is indexed in Jiangsu under Biomedicine. The table below combines recognition context, peer samples and public references for search and review.
Published 2026-06-14. Use company files, policy notices, patent records and the Chinese source report for original-language verification.
Summary
Dizal (Jiangsu) Pharmaceutical Co., Ltd. is indexed in the China Little Giant company database. The profile is associated with Jiangsu. The report is grouped under Biomedicine. Recognition context: 2025 7th batch. Chinese source report date: 2026-06-14. 1 source-page links are available on this page or in the Chinese report. The English brief covers company profile, product direction, industry-chain role, patent and R&D signals, scale indicators and policy-material checkpoints, with internal links to the company page, Chinese source report and related topic hubs.
English Data Summary
This is a structured summary of the portal's recorded company fields, not a full English translation of the Chinese report or an independently verified company thesis.
Recorded Company Profile
- Company: Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Region: Jiangsu
- Recorded industry: Biomedicine
- Recorded chain position: Biomedicine and medical devices / Complete systems and application scenarios
- Recorded recognition context: 2025 7th batch
- Registered-capital field: RMB 465.17 million
- Employee field: 456 employees
- Listing-status field: Listed
Industry-chain Context
Industry and chain-position labels describe the portal's database classification. They do not establish a specific production process, client list, competitive advantage or a company's participation in an adjacent sector.
Database Peer Benchmarks
- Province sample: 3025
- City sample: 472
- Industry sample: 1721
- Province-industry sample: 246
- Same chain-position sample: 1373
- Industry patent percentile: 5
These are database sample statistics, not market shares or audited operating results.
Research Boundary and Original Report
Registration, employee and patent fields retain their recorded database scope; their presence does not establish current capacity, financial performance or ownership of any specific patent. Company-specific products, financial figures, customers and operating claims require the original disclosures. Chinese page provides the corresponding profile and source links. This summary does not constitute investment advice or confirmation of a policy application outcome.
Data Comparison
Peer, chain, region and patent matrices
Core Benchmark
Comparison Dashboard
Sample Base
Province companies3,025
Regional peer baseCity companies472
City-level densityIndustry companies1,721
National industry baseSame chain role1,373
Same chain positionPatent Position
Industry patent percentile5
Ranked against industry peersProvincial segment percentile6
Ranked inside the regional segmentRegional Density
Regional industry peers246
Regional industry baseSame-batch province peers807
Same batch inside provinceIndustry-chain Reading
| Signal | Value | Use |
|---|---|---|
| Company patent count | Not disclosed | Company profile field |
| Industry patent median | 72 | National peer baseline |
| Regional segment median | 87 | Province-industry baseline |
| Industry patent percentile | 5 | Relative IP position |
| Province companies | 3,025 | Regional Little Giant base |
| City companies | 472 | Local density |
| Regional industry peers | 246 | Same province and industry |
| Same-batch province peers | 807 | Recognition-year comparison |
| Same chain-position companies | 1,373 | National chain-position base |
| Same chain-group companies | 1,373 | Broader chain-role base |
Peer Signal Matrix
A compact view of regional density, chain-position density, patent benchmarks and capital-market signals.
| Dimension | Company record | Peer baseline | Reading use |
|---|---|---|---|
| Region | Jiangsu | 3,025 | Province Little Giant base |
| City | China | 472 | Local industrial density |
| Industry | Biomedicine | 1,721 | National industry sample |
| Sub-industry | Biomedicine | 246 | Province-industry sample |
| Chain group | Biomedicine and medical devices | 1,373 | Broad chain peer base |
| Chain node | Complete systems and application scenarios | 1,373 | Same recorded node |
| Regional chain node | Jiangsu | 196 | Same node in province |
| City chain node | China | 21 | Same node in city |
| Patent count | Not disclosed | 72 | Company vs industry median |
| Regional patent median | Not disclosed | 87 | Company vs regional segment |
| Patent percentile | 5% | 6% | Industry and regional percentile |
| Recognition batch | 2025 7th batch | 807 | Same-batch province base |
| Capital / size | RMB 465.17 million | Large enterprise | Registered capital and size field |
| Capital market | 688192 | 72 | Listed peer count in industry |
The matrix uses database fields and internal peer links. Counts are comparison bases, not rankings.
Same province-industry 5Same city 5Same chain node 5Same batch-province 5
Policy Evidence Matrix
| Evidence item | Current record | Source field | Status |
|---|---|---|---|
| Company identity | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Company profile | Profile field |
| Recognition batch | 2025 7th batch | Certification record | Source check |
| Product and chain role | Biomedicine and medical devices / Complete systems and application scenarios | Product and chain fields | Profile field |
| Patent and R&D | Not published · 7.2369 | Patent and R&D fields | Profile field |
| Capital and scale | RMB 465.17 million · 456 employees · Listed | Capital, employee and listing fields | Profile field |
| Public references | 1 linked references | Reference links | Linked source |
Growth and Filing Signals
- Established2017
- Recognized2025
- Current profile2026
| Signal | Record | Use |
|---|---|---|
| Operating years before recognition | 8 years | Recognition timeline |
| R&D field | 7.2369 | Company profile |
| Source coverage | 1 linked sources | Report references |
Peer Benchmark Table
Comparable companies from the same region, city, chain position or recognition batch. Use the table as a navigation layer, not as a ranking.
| Company | Benchmark lens | Region | Industry / chain | Batch | Patents | Employees |
|---|---|---|---|---|---|---|
| Biomedicine and medical devices | Same province and industry | Jiangsu / Chinese source profile field | Biomedicine / Biomedicine and medical devices / Biomedicine and medical devices / Complete systems and application scenarios | 5th batch | 18,274 | 782 |
| Biomedicine and medical devices | Same province and industry | Jiangsu / Suzhou | Biomedicine / Biomedicine and medical devices / Biomedicine and medical devices / Complete systems and application scenarios | 5th batch | 3,338 | 238 |
| Suzhou Iron Technology Co., Ltd. | Same province and industry | Jiangsu / Suzhou | Biomedicine / Biomedicine and medical devices / Biomedicine and medical devices / Complete systems and application scenarios | 3rd batch | 1,683 | 240 |
| Biomedicine and medical devices | Same province and industry | Jiangsu / Chinese source profile field | Biomedicine / Biomedicine and medical devices / Biomedicine and medical devices / Complete systems and application scenarios | 3rd batch | 860 | 303 |
| Biomedicine and medical devices | Same province and industry | Jiangsu / Chinese source profile field | Biomedicine / Biomedicine and medical devices / Biomedicine and medical devices / Complete systems and application scenarios | 2nd batch | 706 | 677 |
| Semiconductors and electronic components | Same city | Jiangsu / Chinese source profile field | Next-generation information technology / Semiconductors and electronic components / Electronic information and digital technology / Process equipment and testing instruments | 4th batch | 3,355 | 254 |
| FAR EAST Composite Technology Co., Ltd. | Same city | Jiangsu / Chinese source profile field | Industrial technology services / New materials / New materials / Base and process materials | 3rd batch | 2,129 | 317 |
| Radio and TV Measurement and Testing (Wuxi) Co., Ltd. | Same city | Jiangsu / Chinese source profile field | Industrial technology services / High-end equipment / High-end equipment and industrial automation / Process equipment and testing instruments | 7th batch | 1,867 | 374 |
| Electronic information and digital technology | Same city | Jiangsu / Chinese source profile field | Next-generation information technology / Semiconductors and electronic components / Electronic information and digital technology / Core components and digital hardware | 4th batch | 1,453 | 163 |
| Ubot (Wuxi) Co., Ltd. | Same city | Shenzhen / Chinese source profile field | High-end equipment / Robotics / High-end equipment and industrial automation / Complete systems and application scenarios | 4th batch | 1,223 | 31 |
Industry Chain
Upstream and Downstream Chain Map
A navigable view of the recorded upstream inputs, current chain node and downstream application side.
Upstream sample profiles
| Item | Record | Use |
|---|---|---|
| Chain group | Biomedicine and medical devices | Use this as the broad industrial-chain context. |
| Current node | Complete systems and application scenarios | 1,373 national peers in the same recorded node. |
| Regional node | Jiangsu | 196 regional peers in the same node. |
| Reading rule | Reference cue | Linked companies show comparable samples, not confirmed customers or suppliers. |
Downstream sample profiles
Region and Batch
Batch and Segment Benchmark
Jiangsu
7th batch
Regional base3,025
Jiangsu Little Giant baseCity base472
City-level cluster densityRegional segment246
Biomedicine sample inside the regionCity segment24
Same-city industry sampleNational chain node1,373
Complete systems and application scenariosRegional chain node196
Biomedicine and medical devicesSame-batch region807
7th batchListed references72
Public-company disclosure references| Lens | Record | Use |
|---|---|---|
| Regional lens | Jiangsu / Biomedicine | 246 regional segment companies |
| Chain lens | Biomedicine and medical devices / Complete systems and application scenarios | 1,373 national node companies |
| Batch lens | 7th batch | 807 same-batch companies in the region |
| Disclosure lens | Listed-company references | 72 listed samples in the industry |
Peer links
Regional Recognition Ladder
Batch-level counts show the province, city and industry recognition rhythm around this company.
NationalJiangsuChinaBiomedicine
| Batch | National | Province | City | Industry |
|---|---|---|---|---|
| 2019 / 1st batch | 248 | 18 | 0 | 32 |
| 2020 / 2nd batch | 1,744 | 99 | 10 | 276 |
| 2021 / 3rd batch | 2,930 | 178 | 22 | 214 |
| 2022 / 4th batch | 4,365 | 425 | 56 | 311 |
| 2023 / 5th batch | 3,671 | 795 | 147 | 292 |
| 2024 / 6th batch | 3,012 | 711 | 113 | 342 |
| 2025 / 7th batch | 3,461 | 807 | 118 | 274 |
Counts come from public company records in the portal database.
Batch Trend by Segment
The trend compares the current industry across national, provincial and city samples by recognition batch.
National industryJiangsuChina
National peak: 2024 / 6th batch. Province peak: 2024 / 6th batch. City peak: 2024 / 6th batch.
| Batch | National industry | Province segment | City segment | Province share |
|---|---|---|---|---|
| 2019 / 1st batch | 32 | 1 | 0 | 3.1% |
| 2020 / 2nd batch | 276 | 12 | 0 | 4.3% |
| 2021 / 3rd batch | 214 | 13 | 2 | 6.1% |
| 2022 / 4th batch | 311 | 38 | 2 | 12.2% |
| 2023 / 5th batch | 292 | 45 | 7 | 15.4% |
| 2024 / 6th batch | 342 | 87 | 8 | 25.4% |
| 2025 / 7th batch | 274 | 51 | 4 | 18.6% |
Counts use public recognition-batch records in the company database.
Industry Concentration Map
Province and city rankings show where the same industry is concentrated in the Little Giant database.
Province ranking
246
164
158
147
112
112
103
83
City ranking
| Rank | Region | Companies | Share |
|---|---|---|---|
| 1 | Beijing / Beijing | 160 | 9.3% |
| 2 | Shanghai / Shanghai | 145 | 8.4% |
| 3 | Shenzhen / Shenzhen | 112 | 6.5% |
| 4 | Jiangsu / Suzhou | 88 | 5.1% |
| 5 | Zhejiang / Hangzhou | 77 | 4.5% |
| 6 | Guangdong / Guangzhou | 73 | 4.2% |
| 7 | Hubei / Wuhan | 45 | 2.6% |
| 8 | Jiangsu | 23 | 1.3% |
Counts use the portal company database and the current industry label.
Patents and Capital
Patent Distribution and Innovation Evidence
Patent count, peer median and percentile signals help check whether IP records support the product and chain narrative.
Patent count
Company patentsNot disclosed
Company profile fieldIndustry median72 records
National peer baselineRegional segment median87 records
Province-industry baselinePeer percentile
Industry percentile5%
Compared with national industry peersRegional segment percentile6%
Compared inside the regional segment| Check item | Record | Use |
|---|---|---|
| Patent ownership | Check title, owner and validity | Patent lists should match the filing entity and main product. |
| Product relevance | Match patents to core products | A high count matters less if the technology is off the main business. |
| Peer position | Use median and percentile | Compare against same industry and same province-industry samples. |
Patent-heavy peer profiles
Report Snapshot
| Company | Dizal (Jiangsu) Pharmaceutical Co., Ltd. |
| Region | Jiangsu |
| Industry | Biomedicine |
| Published | 2026-06-14 |
| Chinese report | Open Chinese report |